STOCK TITAN

AbbVie to Present at the Bank of America Securities Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie will participate in the Bank of America Securities Healthcare Conference on May 15, 2024. The company's key executives will present at the conference, and a live audio webcast will be accessible through AbbVie's Investor Relations website.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., May 6, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical officer, global therapeutics, will present at 12:40 p.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. 

AbbVie logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bank-of-america-securities-healthcare-conference-302133591.html

SOURCE AbbVie

FAQ

When will AbbVie participate in the Bank of America Securities Healthcare Conference?

AbbVie will participate in the conference on May 15, 2024.

Who will be presenting at the conference from AbbVie?

Key executives including Robert A. Michael, Scott T. Reents, Jeffrey R. Stewart, and Roopal Thakkar, M.D. will be presenting.

How can I access the live audio webcast of the presentation?

The live audio webcast will be accessible through AbbVie's Investor Relations website at investors.abbvie.com.

Will there be an archived edition of the session available?

Yes, an archived edition of the session will be available later on the same day.

AbbVie Inc.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

293.88B
1.76B
0.11%
71.92%
0.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NORTH CHICAGO

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.